Differential induction of mucosal and systemic antibody responses in women after nasal, rectal, or vaginal immunization: Influence of the menstrual cycle

Journal of Immunology

Volumn 169, Issue 1, 2002, Pages 566-574

  Kozlowski, Pamela A ^a   Williams, Selvi B ^a   Lynch, Rebecca M ^a   Flanigan, Timothy P ^a   Patterson, Rosalyn R ^a   Cu Uvin, Susan ^a   Neutra, Marian R ^a  

^a BOSTON CHILDREN S HOSPITAL   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

BACTERIUM LIPOPOLYSACCHARIDE; CHOLERA TOXIN B SUBUNIT; CHOLERA VACCINE; IMMUNOGLOBULIN A; IMMUNOGLOBULIN A ANTIBODY; IMMUNOGLOBULIN A2; IMMUNOGLOBULIN G; IMMUNOGLOBULIN G ANTIBODY; IMMUNOGLOBULIN M ANTIBODY;

ADULT; ANTIBODY RESPONSE; ARTICLE; CLINICAL ARTICLE; CONTROLLED STUDY; ENZYME LINKED IMMUNOSORBENT ASSAY; FEMALE; FEMALE GENITAL SYSTEM; FOLLICULAR PHASE; HUMAN; IMMUNIZATION; LUTEAL PHASE; MENSTRUAL CYCLE; NOSE MUCOSA; PRIORITY JOURNAL; RECTUM MUCOSA; SALIVA LEVEL; SERUM; SEXUALLY TRANSMITTED DISEASE; UTERINE ENDOCERVIX; VAGINA MUCOSA;

EID: 0036644724     PISSN: 00221767     EISSN: None     Source Type: Journal    
DOI: 10.4049/jimmunol.169.1.566     Document Type: Article

References (50)

1. Long-term immunity and protection against herpes simplex virus type 2 in the murine female genital tract after mucosal but not systemic immunization
2. Mucosal AIDS vaccine reduces disease and viral load in gut reservoir and blood after mucosal infection of macaques
3. Evidence for early local viral replication and local production of antiviral immunity upon mucosal simian-human immunodeficiency virus SHIV (89.6) infection in Macaca nemestrina
4. Human immunodeficiency virus type 1 gag-specific vaginal immunity and protection after local immunizations with Sindbis-virus based replicon particles
5. Identification of SIV env-specific CTL in the jejunal mucosa in vaginally exposed, seronegative rhesus macaques (Macaca mulatta)
6. Immunization of mice with recombinant gp41 in a systemic prime/mucosal boost protocol induces HIV-1-specific serum IgG and secretory IgA antibodies
7. Comparison of the oral, rectal, and vaginal immunization routes for induction of antibodies in rectal and genital tract secretions of women
8. Mucosal vaccination strategies for women
9. Nasal and vaginal vaccinations have differential effects on antibody responses in vaginal and cervical secretions in humans
10. Influence of the estrous cycle on the presence and distribution of immune cells in the rat reproductive tract
11. Antigen-presenting cells in the female genital tract: Influence of sex hormones on antigen presentation in the vagina
12. Langerhans cells and T lymphocyte subsets in the murine vagina and cervix
13. Vaginal mucosa serves as an inductive site for tolerance
14. Antigen recognition in the female reproductive tract. I. Uptake of intraluminal protein tracers in the mouse vagina
15. A recombinant Salmonella typhimurium vaccine induces local immunity by four different routes of immunization
16. The effect of one injection of Depo-Provera on the human vaginal epithelium and cervical ectopy
17. Langerhan's cells and lymphocyte subsets in the female genital tract
18. A study of the secretory immune system of the female genital tract
19. The number and distribution of immune cells in the cervicovaginal mucosa remain constant throughout the menstrual cycle of rhesus macaques
20. The importance of mucosal immunology to problems in human reproduction
21. Mucosal immunity in the female genital tract: Relevance to vaccination efforts against the human immunodeficiency virus
22. Langerhans cells, macrophages and lymphocyte subsets in the cervix and vagina of rhesus macaques
23. Distribution of lymphocytes and adhesion molecules in human cervix and vagina
24. + T cell-rich lymphoid aggregates in human uterine endometrium
25. + CTL activity within the female reproductive tract: Influence of stage of the menstrual cycle and menopause
26. Antibody responses in the lower respiratory tract and male urogenital tract in humans after nasal and oral vaccination with cholera toxin B subunit
27. Intranasal vaccination of humans with recombinant cholera toxin B subunit induces systemic and local antibody responses in the upper respiratory tract and the vagina
28. Human immune responses to influenza virus vaccines administered by systemic or mucosal routes
29. Differences in immune responses induced by oral and rectal immunizations with Salmonella typhi Ty21a: Evidence for compartmentalization within the common mucosal immune system in humans
30. Specific-antibody-secreting cells in the rectums and genital tracts of nonhuman primates following vaccination
31. Induction of mucosal immunity by intranasal application of a streptococcal surface protein antigen with the cholera toxin B subunit
32. Intranasal immunization is superior to vaginal, gastric, or rectal immunization for induction of systemic and mucosal anti-HIV antibody responses
33. The normal menstrual cycle: Changes throughout life
34. Modified wick method using Weck-Cel sponges for collection of human rectal secretions and analysis of mucosal HIV antibody
35. Soluble proteins in cervical mucus
36. Immunoglobulin concentrations and antigen-specific antibody levels in cervicovaginal lavages of rhesus macaques are influenced by the stage of the menstrual cycle
37. Hormonal regulation of the secretory IgA (sIgA) system: Estradiol- and progesterone-induced changes in sIgA in parotid saliva along the menstrual cycle
38. Detection of mucosal antibodies in HIV-infected individuals
39. Molecular heterogeneity of human IgA antibodies during an immune response
40. Serum IgA subclasses and molecular forms in HIV infection: Selective increases in monomer and apparent restriction of the antibody response to IgA1 antibodies mainly directed at env glycoproteins
41. Induction of mucosal and systemic immune responses by intranasal immunization using recombinant cholera toxin B subunit as an adjuvant
42. Recombinant cholera toxin B subunit acts as an adjuvant for the mucosal and systemic responses of mice to mucosally co-administered bovine serum albumin
43. Salivary, nasal, genital, and systemic antibody responses in monkeys immunized intranasally with a bacterial protein antigen and cholera toxin B subunit
44. Immune modulation by the cholera-like enterotoxins: From adjuvant to therapeutic
45. Antigen sampling across epithelial barriers and induction of mucosal immune responses
46. Humoral immune responses to microbial infections in the genital tract
47. The immune response during the luteal phase of the ovarian cycle: A Th2-type response?
48. Distribution of Th1, Th2, and Th0 and the Th1/Th2 cell ratios in human peripheral blood and endometrial T cells
49. Mucosal adjuvants
50. gag and cholera toxin elicits both mucosal IgA and systemic IgG immune responses in nonhuman primates